Shanghai, China The main office of represented VC is situated in the Shanghai. The company was established in Asia in China.
The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Publishing, Genetics. Among the most popular portfolio startups of the fund, we may highlight Xueba100.com, Prenetics, Soul. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Magic Capital, startups are often financed by GSR Ventures, Coent Venture Partners, Capital Union Investments. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures China, Vertex Ventures, Beyond Ventures. In the next rounds fund is usually obtained by IDG Capital, Walden International, Yada Education.
The fund was created by Colin Huang, Hongyu Zhang, Joe Wu.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Weiming Smart | 30 Nov 2021 | Jingan, Shanghai, China | |||
Xiaoyezi | $30M | 08 Nov 2021 | Beijing, Beijing, China | ||
Grand Voyage Holdings | 20 Feb 2021 | England | |||
APstem Therapeutics, Inc. | $2M | 01 Sep 2020 | Fremont, California, United States | ||
Bouffalo Lab | $26M | 01 Feb 2020 | Shanghai, China | ||
TeatreeGroup | 19 Dec 2019 | China, Beijing | |||
Infimind | $14M | 16 Oct 2019 | Dongcheng District, Beijing, China | ||
APstem Therapeutics, Inc. | $500K | 01 May 2019 | Fremont, California, United States | ||
Candao | $15M | 16 Apr 2019 | Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Weiming Smart | 30 Nov 2021 | Jingan, Shanghai, China | |||
Xiaoyezi | $30M | 08 Nov 2021 | Beijing, Beijing, China | ||
Grand Voyage Holdings | 20 Feb 2021 | England | |||
APstem Therapeutics, Inc. | $2M | 01 Sep 2020 | Fremont, California, United States | ||
Bouffalo Lab | $26M | 01 Feb 2020 | Shanghai, China | ||
TeatreeGroup | 19 Dec 2019 | China, Beijing | |||
Infimind | $14M | 16 Oct 2019 | Dongcheng District, Beijing, China | ||
APstem Therapeutics, Inc. | $500K | 01 May 2019 | Fremont, California, United States | ||
Candao | $15M | 16 Apr 2019 | Guangdong Province |
